| Target Price | $0.38 |
| Price | $0.02 |
| Potential |
1,563.04%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Galera Therapeutics Inc 2026 .
The average Galera Therapeutics Inc target price is $0.38.
This is
1,563.04%
register free of charge
$0.53
2,182.61%
register free of charge
$0.25
997.83%
register free of charge
|
|
| A rating was issued by 7 analysts: 0 Analysts recommend Galera Therapeutics Inc to buy, 4 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Galera Therapeutics Inc stock has an average upside potential 2026 of
1,563.04%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.35 | -0.80 |
| 73.68% | 128.57% | |
| P/E | negative | |
| EV/Sales | 1.16 |
3 Analysts have issued a Galera Therapeutics Inc forecast for earnings per share. The average Galera Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
| 2024 | $-0.35 | 73.68% |
|---|---|---|
| 2025 |
$-0.80
128.57%
Unlock
|
|
| Current | -0.18 | 31.25% |
|---|---|---|
| 2025 |
-0.03
83.54%
Unlock
|
|
Galera Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


